| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |